PL3746114T3 - Kompozycje do zastosowania w leczeniu zaćmy - Google Patents

Kompozycje do zastosowania w leczeniu zaćmy

Info

Publication number
PL3746114T3
PL3746114T3 PL19702553.9T PL19702553T PL3746114T3 PL 3746114 T3 PL3746114 T3 PL 3746114T3 PL 19702553 T PL19702553 T PL 19702553T PL 3746114 T3 PL3746114 T3 PL 3746114T3
Authority
PL
Poland
Prior art keywords
compositions
treat cataract
cataract
treat
Prior art date
Application number
PL19702553.9T
Other languages
English (en)
Inventor
Elisabeth VAN AKEN
Joris Delanghe
Nico Callewaert
Loes VAN SCHIE
Original Assignee
Universiteit Gent
Vib Vzw
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universiteit Gent, Vib Vzw filed Critical Universiteit Gent
Publication of PL3746114T3 publication Critical patent/PL3746114T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45Transferases (2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y207/00Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/01171Protein-fructosamine 3-kinase (2.7.1.171)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL19702553.9T 2018-01-30 2019-01-28 Kompozycje do zastosowania w leczeniu zaćmy PL3746114T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18154064 2018-01-30
PCT/EP2019/051961 WO2019149648A1 (en) 2018-01-30 2019-01-28 Compositions for use to treat cataract

Publications (1)

Publication Number Publication Date
PL3746114T3 true PL3746114T3 (pl) 2023-01-16

Family

ID=61094279

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19702553.9T PL3746114T3 (pl) 2018-01-30 2019-01-28 Kompozycje do zastosowania w leczeniu zaćmy

Country Status (7)

Country Link
US (1) US11478499B2 (pl)
EP (1) EP3746114B1 (pl)
JP (1) JP7213891B2 (pl)
CA (1) CA3088239A1 (pl)
ES (1) ES2917628T3 (pl)
PL (1) PL3746114T3 (pl)
WO (1) WO2019149648A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12171811B2 (en) 2018-09-14 2024-12-24 Universiteit Gent Compositions for use to treat advanced glycation end products-dependent ocular diseases
EP4245371A4 (en) * 2020-11-17 2024-11-13 Nagase Viita Co., Ltd. Crystalline lens hardness adjustment agent
CA3210369A1 (en) * 2021-03-08 2022-09-15 Universiteit Gent Treatment of eye diseases with fructosyl-amino acid oxidase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003222533A1 (en) * 2002-04-29 2003-11-17 Protemix Corporation Limited Proteins with deglycating activities and methods of using same
EP2152231A1 (en) * 2007-06-11 2010-02-17 Chanel Parfums Beauté Use of active agents for stimulating the expression of fn3k and/or fn3k rp for combating ageing of the skin
CA2853379C (en) * 2011-10-27 2020-11-24 Wellstat Ophthalmics Corporation Vectors encoding rod-derived cone viability factor
US20180325854A1 (en) 2015-11-06 2018-11-15 Accuitis Pharmaceuticals, Inc. Use of proteasome inhibitors to treat ocular disorders

Also Published As

Publication number Publication date
JP7213891B2 (ja) 2023-01-27
US20210030780A1 (en) 2021-02-04
CA3088239A1 (en) 2019-08-08
ES2917628T3 (es) 2022-07-11
WO2019149648A1 (en) 2019-08-08
JP2021515803A (ja) 2021-06-24
EP3746114A1 (en) 2020-12-09
US11478499B2 (en) 2022-10-25
EP3746114B1 (en) 2022-05-04

Similar Documents

Publication Publication Date Title
SG11202105907QA (en) Compositions for drg-specific reduction of transgene expression
ZA201803530B (en) Compounds and compositions useful for treating disorders related to ntrk
ZA201801881B (en) Compounds and compositions useful for treating disorders related to ntrk
ZA202006610B (en) Compositions for the treatment of skin conditions
GB201715639D0 (en) Compositions for wound treatment
SG11201705093UA (en) Composition for treating il-6-related diseases
IL246791A0 (en) Compositions and methods for treating eye diseases
ZA202007055B (en) Compositions for the treatment of skin conditions
IL258032A (en) Compounds and preparations for the treatment of ocular disorders
IL249938B (en) Preparations of antiviral substances for preventive treatment
IL261774B (en) Preparations for the treatment of skin problems
PT3573620T (pt) Composições para o tratamento da hipertensão
EP3160460A4 (en) Ketobutyrate compounds and compositions for treating age-related symptoms and diseases
IL249640A0 (en) Preparations for the treatment of nosebleeds
PL3493823T3 (pl) Składnik na bazie postbiotyki do leczenia zapalenia oka
SG11202008959RA (en) Composition for improving skin conditions
GB201707462D0 (en) Ocular compositions
SG11202006144XA (en) Composition for protecting cornea
PL3746114T3 (pl) Kompozycje do zastosowania w leczeniu zaćmy
SMT202300229T1 (it) Composizioni per trattare condizioni oftalmiche
IL252543A0 (en) Compounds for the treatment of degenerative retinal tissues
PL3849596T3 (pl) Kompozycje do zastosowania w leczeniu chorób oczu zależnych od końcowych produktów zaawansowanej glikacji
IL263336B (en) Compounds for the treatment of symphysiolysis
GB201813783D0 (en) Therapeutic compositions
GB201811726D0 (en) Therapeutic compositions